The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer represents a premium of 38.3% to Masimo's last close.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...

Masimo Corp. in Irvine now sells its MightySat pulse oximeter in about 100 Apple stores and on Apple.com. It previously had been available only online at a roster of websites that include Amazon.com ...

Masimo Corporation MASI recently announced the FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over-The-Counter (OTC) to consumers without a prescription. This ...

Masimo iSpO2 pulse oximeter and the iSpO2 app. Manufactured and submitted by Masimo Corp. (Irvine, CA). The iSpO2 is a measure-through-motion and low-perfusion pulse oximeter made for iPhone and iPad.

Wearable devices have become essential to clinical research, as they enable research studies to collect health-related data on patients around the clock. These devices, which includes commercial ...

This morning medical device company Masimo announced FDA clearance for the measurement of respiration rate from a photoplethysmogram (RRp), so that it may now be used on the MightSat Rx finger pulse ...

Apple on Thursday began selling revised models of the Apple Watch Series 9 and Ultra 2 in the US without the blood oxygen feature as the company faces a patent dispute with medical company Masimo. In ...

Masimo Corp., an Irvine-based medical device maker, won another round in a long-running patent scrum with a larger rival. The U.S. Court of Appeals in Washington, D.C., upheld a $164.5 million jury ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of the Rad-G™ Pulse Oximeter, a rugged handheld device that provides clinically proven SET ® pulse oximetry, ...